Cargando…
Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients
In some settings, cancer cells responding to treatment undergo an immunogenic form of cell death that is associated with the abundant emission of danger signals in the form of damage-associated molecular patterns. Accumulating preclinical and clinical evidence indicates that danger signals play a cr...
Autores principales: | Truxova, Iva, Kasikova, Lenka, Salek, Cyril, Hensler, Michal, Lysak, Daniel, Holicek, Peter, Bilkova, Pavla, Holubova, Monika, Chen, Xiufen, Mikyskova, Romana, Reinis, Milan, Kovar, Marek, Tomalova, Barbora, Kline, Justin P., Galluzzi, Lorenzo, Spisek, Radek, Fucikova, Jitka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327638/ https://www.ncbi.nlm.nih.gov/pubmed/31582537 http://dx.doi.org/10.3324/haematol.2019.223933 |
Ejemplares similares
-
Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients
por: Holicek, Peter, et al.
Publicado: (2023) -
TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients
por: Rakova, Jana, et al.
Publicado: (2021) -
Calreticulin arms NK cells against leukemia
por: Fucikova, Jitka, et al.
Publicado: (2019) -
Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients
por: Kasikova, Lenka, et al.
Publicado: (2019) -
Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy
por: MIKYŠKOVÁ, ROMANA, et al.
Publicado: (2015)